Galcanezumab (RxNorm)

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.651
Version
20231215
PublisherAmerican Academy of Neurology StewardDate2023-12-15T19:18:20-05:00Purpose

(Clinical Focus: Long term preventive medication for cluster headache.),(Data Element Scope: Treatment),(Inclusion Criteria: Galcanezumab medication),(Exclusion Criteria: None)

Expansion
<<>>>
CodeDisplaySystem
2058874http://www.nlm.nih.gov/research/umls/rxnorm
2170611http://www.nlm.nih.gov/research/umls/rxnorm
2058869http://www.nlm.nih.gov/research/umls/rxnorm
2058886http://www.nlm.nih.gov/research/umls/rxnorm
2170613http://www.nlm.nih.gov/research/umls/rxnorm
2058885http://www.nlm.nih.gov/research/umls/rxnorm
2170612http://www.nlm.nih.gov/research/umls/rxnorm
2058872http://www.nlm.nih.gov/research/umls/rxnorm
2058877http://www.nlm.nih.gov/research/umls/rxnorm
2058887http://www.nlm.nih.gov/research/umls/rxnorm
2170610http://www.nlm.nih.gov/research/umls/rxnorm